These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 5288786)

  • 1. [Calcintonin--an antiosteoporosis hormone?].
    Dambacher MA; Olah AJ; Guncaga J; Lentner C; Lauffenburger T; Haas HG
    Helv Med Acta Suppl; 1970 Jun; ():Suppl 50:137. PubMed ID: 5288786
    [No Abstract]   [Full Text] [Related]  

  • 2. [Long-term treatment with thyrocalcitonin in senile osteoporosis: studies with radio-calcium].
    Caniggia A; Gennari C; Bencini M; Cesari L; Borrello G
    Boll Soc Ital Biol Sper; 1970 Jan; 46(2):86-8. PubMed ID: 5419776
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term treatment with thyrocalcitonin in senile osteoporosis: metabolic aspects].
    Caniggia A; Gennari C; Bencini M; Cesari L; Borrello G
    Boll Soc Ital Biol Sper; 1970 Jan; 46(2):85-6. PubMed ID: 5419775
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metabolic rates and histological-morphometrical investigations in bones of patients wtth osteoporosis subjected to long-term application of calcitonin].
    Dambacher MA; Olah AJ; Guncaga J; Lentner C; Haas HG
    Acta Endocrinol Suppl (Copenh); 1971; 152():87. PubMed ID: 5313712
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute effects of administered calcitonin in man.
    Singer FR; Foster GV; Jpolin GF; Nadarajah A; Parkinson DK; Thalassinos N; Woodhouse NJ; Clark MB; Fraser TR; MacIntyre I
    Calcif Tissue Res; 1968; ():Suppl:20. PubMed ID: 5721055
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long term treatment of osteoporosis with thyrocalcitonin. Apropos of 7 cases].
    Bloch-Michel H; Milhaud G; Coutris G; Waltzing P; Charret A; Morin Y; Verger D; Dussart N
    Rev Rhum Mal Osteoartic; 1970 Oct; 37(10):629-38. PubMed ID: 5482813
    [No Abstract]   [Full Text] [Related]  

  • 7. An evaluation of several biochemical markers for bone formation and resorption in a protocol utilizing cyclical parathyroid hormone and calcitonin therapy for osteoporosis.
    Hodsman AB; Fraher LJ; Ostbye T; Adachi JD; Steer BM
    J Clin Invest; 1993 Mar; 91(3):1138-48. PubMed ID: 8450043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical experience with porcine thyrocalcitonin in the treatment of senile osteoporosis].
    Boni A
    Clin Ter; 1980 Aug; 94(3):325-34. PubMed ID: 7449349
    [No Abstract]   [Full Text] [Related]  

  • 9. [Behavior of urinary excretion of cyclic AMP in post-menopausal osteoporosis during therapy with salmon calcitonin].
    Nuti R; Galli M; Righi GA; Turchetti V; Campagna MS; Franci B
    Minerva Med; 1982 May; 73(19):1283-9. PubMed ID: 6281691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcitonins and osteoporosis.
    Gennari C; Agnusdei D
    Br J Clin Pract; 1994; 48(4):196-200. PubMed ID: 7917799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current treatment concepts in primary osteoporosis: calcitonin].
    Ringe JD
    Schweiz Med Wochenschr; 1993 Nov; 123(47):2235-40. PubMed ID: 8272794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcitonin -- 1998].
    Lorenc RS
    Pol Merkur Lekarski; 1998 Oct; 5(28):236-7. PubMed ID: 10101452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical applications of calcitonin.
    Can Med Assoc J; 1971 Aug; 105(3):238-9. PubMed ID: 5563336
    [No Abstract]   [Full Text] [Related]  

  • 14. Calcitriol in disorders of bone and calcium metabolism.
    Riggs BL
    Clin Ther; 1980; 3(1):33-9. PubMed ID: 6893296
    [No Abstract]   [Full Text] [Related]  

  • 15. Drugs for postmenopausal osteoporosis.
    Med Lett Drugs Ther; 1980 May; 22(11):45-6. PubMed ID: 7374621
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment options in osteoporosis.
    Seal R
    Community Nurse; 1997 Jan; 2(11):21-2. PubMed ID: 9451092
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of glucocorticoid-induced osteoporosis.
    Cohen D; Adachi JD
    J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):337-49. PubMed ID: 15145443
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The role of calcitonin in treatment of osteoporosis].
    Sawicki A
    Pol Tyg Lek; 1993 Nov; 48 Suppl 3():58-60. PubMed ID: 8309842
    [No Abstract]   [Full Text] [Related]  

  • 19. [Development, chemistry, and clinical pharmacology of fully synthetic human calcitonin (author's transl)].
    Hobitz H
    Wien Klin Wochenschr; 1982 Feb; 94(3):67-75. PubMed ID: 7043901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on pharmacologic therapies for osteoporosis.
    Kessenich CR
    Nurse Pract; 1996 Aug; 21(8):19-24. PubMed ID: 8871987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.